Details of Host Protein-DME Interaction (HOSPPI)
| General Information of Drug-Metabolizing Enzyme (DME ID: DME0548) | |||||
|---|---|---|---|---|---|
| DME Name | Dimethylarginine dimethylaminohydrolase 1 (DDAH1), Homo sapiens | DME Info | |||
| UniProt ID | |||||
| EC Number | EC: 3.5.3.18 (Click to Show/Hide the Complete EC Tree) | ||||
| Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
| Interactome | |||||
| Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
|---|---|---|---|---|---|
| ICD Disease Classification Healthy | |||||
| ICD-11: Healthy | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| Non-coding RNA regulation | |||||
| hsa-miR-210-3p | Health | Suppression | |||
| miRBase ID | |||||
| Interaction Name | hsa-miR-210-3p--DDAH1 regulation | [1] | |||
| Studied Cell Lines | HEK293 cell line | ||||
| Description | hsa-miR-210-3p is reported to suppress DDAH1 mRNA translation by binding to the 3' untranslated region (3'UTR) of DDAH1 mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Dimethylarginine dimethylaminohydrolase 1. | ||||
| ICD Disease Classification 02 Neoplasms | |||||
| ICD-11: 2A00 Brain cancer | Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Brain neuroblastoma | Significant hypomethylation | |||
| Interaction Name | DNMT-DDAH1 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 2.19E-21; delta-beta: -6.14E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the DDAH1 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Dimethylarginine dimethylaminohydrolase 1. As a result, the interaction between DNMT and DDAH1 can significantly affect the drug-metabolizing process of Dimethylarginine dimethylaminohydrolase 1. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| DNA methyltransferase (DNMT) | Vestibular melanotic schwannoma | Moderate hypomethylation | |||
| Interaction Name | DNMT-DDAH1 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypomethylation p-value: 5.66E-05; delta-beta: -2.18E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the DDAH1 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Dimethylarginine dimethylaminohydrolase 1. As a result, the interaction between DNMT and DDAH1 can moderatly affect the drug-metabolizing process of Dimethylarginine dimethylaminohydrolase 1. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD-11: 2C25 Lung cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| Non-coding RNA regulation | |||||
| hsa-miR-21-5p | Lung cancer | Suppression | |||
| miRBase ID | |||||
| Interaction Name | hsa-miR-21-5p--DDAH1 regulation | [2] | |||
| Studied Cell Lines | A549 cell line | ||||
| Description | hsa-miR-21-5p is reported to suppress DDAH1 mRNA translation by binding to the 3' untranslated region (3'UTR) of DDAH1 mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Dimethylarginine dimethylaminohydrolase 1. | ||||
| ICD Disease Classification 11 Circulatory system diseases | |||||
| ICD-11: BD51 Arterial aneurysm | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Arterial aneurysm | Significant hypermethylation | |||
| Interaction Name | DNMT-DDAH1 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 3.44E-02; delta-beta: 4.12E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the DDAH1 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Dimethylarginine dimethylaminohydrolase 1. As a result, the interaction between DNMT and DDAH1 can significantly affect the drug-metabolizing process of Dimethylarginine dimethylaminohydrolase 1. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

